Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Papillomavirus Infections × Sodium Chloride × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 32 Neoplasms 11 Pain, Postoperative 10 Colorectal Neoplasms 10 Lung Neoplasms 9 Brain Neoplasms 8 Stomach Neoplasms 7 Prostatic Neoplasms 7 Pancreatic Neoplasms 7 Carcinoma, Non-Small-Cell Lung 7 Melanoma 6 Leukemia, Myeloid, Acute 5 Ovarian Neoplasms 4 Myoma 4 Lymphoma, Non-Hodgkin 4 Leiomyoma 4 Hemorrhage 4 Glioblastoma 4 Colonic Neoplasms 4 Agnosia 4 Skin Neoplasms 3 Recurrence 3 Rectal Neoplasms 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 3 Neoplasm Metastasis 3 Nasopharyngeal Carcinoma 3 Myelodysplastic Syndromes 3 Hodgkin Disease 3 Head and Neck Neoplasms 3 Fatigue 3

Interventions

human papillomavirus vaccine, L1 type 16, 18 34 Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 27 Papillomavirus Vaccines 22 Vaccines 11 Human Papillomavirus Recombinant Vaccine nonavalent 10 Radiotherapy, Intensity-Modulated 7 Human Papillomavirus DNA Tests 7 Colposcopy 7 Cisplatin 7 Carboplatin 6 Vaccines, Synthetic 5 Specimen Handling 5 Educational Status 5 Blood Specimen Collection 5 Vaginal Smears 4 Engerix-B 4 Early Intervention, Educational 4 fludarabine 3 artesunic acid 3 artemisinin 3 Watchful Waiting 3 Surveys and Questionnaires 3 Paclitaxel 3 Methods 3 Imiquimod 3 Hepatitis A Vaccines 3 Cyclophosphamide 3 halofantrine 2 fludarabine phosphate 2 epigallocatechin gallate 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04199689 2025-03-25

V503-049

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting

Papillomavirus Infections

Data powered by HemOnc (CC BY 4.0) Colophon ⚡